ARTICLE: US Guidelines Fall Short on Short-Course Tuberculosis-Preventive Therapy
AUTHORS: Sonya Krishnan, Richard E Chaisson
JOURNAL: Clin Infect Dis. 2024 Mar 20;78(3):514-517. doi: 10.1093/cid/ciad659.
Abstract
The provision of tuberculosis-preventive therapy (TPT) to vulnerable populations is critical for global control. Shorter-course TPT regimens are highly effective and improve completion rates. Despite incorporation of 1 month of rifapentine and isoniazid into global guidelines, current US TPT guidelines do not include this as a recommended regimen, but should.
For the full article, click here.
For a link to the abstract, click here.
